Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The Galien Foundation Announces 2025 Prix Galien UK Forum and Awards Ceremony in London on 5 June

This image opens in the lightbox

News provided by

The Galien Foundation

08 May, 2025, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

A day of expert panels and prestigious honours for the UK's most impactful health innovations

LONDON, May 8, 2025 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, is proud to announce the Prix Galien UK Forum and Awards Ceremony will take place on Wednesday, 5 June, 2025, in London.

Celebrating excellence in life sciences, biotechnology, and pharmaceutical innovation, the 2025 event will bring together industry leaders, researchers, policymakers, and patient advocates to engage in meaningful dialogue on the future of health and medicine. The Forum, hosted at the Science Museum, will feature a full day of thought-provoking panels, followed by the prestigious Prix Galien UK Awards Ceremony at the Natural History Museum, featuring this year's illustrious keynote speaker, Roland Sinker, CBE, Chief Executive of the Cambridge University Hospitals NHS Foundation Trust.

The 2025 Forum will also include two keynote presentations from Prof. Ara Darzi, Baron Darzi of Denham, Paul Hamlyn Chair of Surgery and Co-Director of the Institute of Global Health Innovation at Imperial College London, and Dr. Tony Wood, Chief Scientific Officer, GSK. This year's Forum panels will tackle some of the most pressing and promising areas of health innovation, including:

Panel 1: Advances in International HTA Collaboration: How will joint clinical assessments impact patient access to medicines in Europe?

  • Chair:
    • Dr. Mel Walker, Life Sciences Strategic Advisor and CEO, Access InVivo
  • Panelists:
    • Niklas Hedberg, Chief Pharmacist at the Swedish national governmental authority, the Dental and Pharmaceuticals Benefits Agency and Co-Chair, the EU Member States Coordination Group under HTAR
    • Dr. Sam Roberts, Chief Executive, NICE
    • Dr. Gregory Rossi, Senior Vice President Head of Oncology Europe and Canada, AstraZeneca
    • Valentina Strammiello, Director of Strategic Initiatives at the European Patients Forum
    • Dr. Steffen Thirstrup, Chief Medical Officer at European Medicines Agency

Panel 2: Advances in Individualised Medicine: Are breakthrough therapies for ultra rare diseases within reach?

  • Chair:
    • Dame June Raine, Former Chief Executive, Medicines and Healthcare Products Regulatory Agency
  • Panelists:
    • Avril Daly, President of EURORDIS
    • Dr. Gregory Friberg, Chief Research & Development Officer, BioMarin Pharmaceutical
    • Dame Sue Hill, CSO for England, Senior Responsible Officer for Genomics in the NHS
    • Dr. Janet Woodcock, Former Director of the Center for Drug Evaluation and Research and Principal Deputy Commissioner of the U.S. Food and Drug Administration
    • Prof. Matthew Wood, Professor of Neuroscience, Deputy Head Medical Sciences Division (Innovation), University of Oxford, Director and Chief Scientific Officer Oxford-Harrington Rare Disease Centre, Adjunct Professor of Medicine, Case Western Reserve University School of Medicine

Panel 3: Advances in Treatment for Obesity and its Co-Morbidities: Global Challenges and Opportunities for Prevention and Population Health

  • Chair:
    • Naveed Sattar, Professor of Cardiometabolic Medicine, University of Glasgow, and Chair of Obesity Healthcare Goals Programme
  • Panelists:
    • Prof. Rachel Batterham, Senior Vice President of International Medical Affairs at
    • Eli Lilly and Company
    • Prof. Melanie Davies, Professor of Diabetes Medicine, University of Leicester
    • Prof. Simon Griffin, Professor of General Practice, University of Cambridge
    • Vicki Mooney, Executive Director, European Coalition for People living with Obesity

Panel 4: Advances in the Treatment of Symptoms in Mental Health/Mood Disorders: How can healthcare systems deliver solutions at scale to address the global mental health crisis?

  • Chair:
    • Prof. Kathryn Abel, Mental Health Mission Co-Chair; European Research Council Fellow and National Institutes of Health Research Senior Investigator
  • Panelists:
    • Prof. Michael Browning, Lead of Mood Disorders Translational Research Collaboration, Honorary Consultant Psychiatrist and Professor of Computational Psychiatry at the University of Oxford
    • Andrew Grill, Actionable Futurist and Bestselling Author of Digitally Curious
    • Dr. Vanessa Pinfold, Co-Founder/Research Director, McPin Foundation and Chair of the Alliance of Mental Health Research Funders
    • Catherine Owen Adams, CEO Acadia Pharma
    • Sanket Shah, President & Board Member, Otsuka Precision Health

"The Prix Galien UK Forum and Awards Ceremony represents a vital opportunity to spotlight the trailblazers who are redefining the future of global health. By bringing together the world's top scientists, innovators, and advocates, we not only celebrate life-changing achievements but also foster the cross-sector collaboration needed to drive the next wave of discovery. It is an honour to support and recognise those who work tirelessly to improve the human condition," said Bruno Cohen, Chairman of The Galien Foundation.

Following the Galien Forum, the Prix Galien Awards Ceremony will honour winners in the following categories: "Best Pharmaceutical Product," "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology Product," "Best Public Sector Innovation," and "Best Health Equity Innovation."  

"As science advances at an extraordinary pace, events like the Prix Galien UK Forum and Awards Ceremony are essential in highlighting and celebrating how research can be translated into real-world health impact," said Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine, University of Liverpool; NHS Chair of Pharmacogenetics, Chair of the Prix Galien UK Committee. "From personalised medicine to equitable access, we have the tools and the knowledge to transform patient care across the globe. It is a privilege to contribute to a platform that champions innovation with purpose."

To learn more about the Prix Galien UK Forum and register to attend, please visit: https://www.galienfoundation.org/galien-forum-uk-2025-program

About The Galien Foundation
The Galien Foundation fosters, recognises and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.

The Galien Foundation oversees and directs the Prix Galien's activities in the UK as part of an international awards program dedicated to advancing innovative medicines development. The Prix Galien operates through chapters in 14 countries and Africa, with a new chapter launched in India in 2024 and plans for Prix Galien Japan in 2026. The Prix Galien was created in 1970 by Roland Mehl in honour of Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

For more information, visit www.galienfoundation.org.

Follow the Foundation on social media: 
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/

Media Contact (UK):
Julian Tyndale-Biscoe
Finn Partners
Julian.Tyndale-biscoe@finnpartners.com
+44 20 3217 7060

Media Contact (Global):
Kara Bradley
Finn Partners
Kara.Bradley@finnpartners.com
646-213-7243

Logo - https://mma.prnewswire.com/media/2592709/The_Galien_Foundation_Logo.jpg

Modal title

Also from this source

The Galien Foundation Announces 2025 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product," "Best Public Sector Innovation" and "Best Health Equity Innovation"

The Galien Foundation Announces 2025 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product," "Best Public Sector Innovation" and "Best Health Equity Innovation"

The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2025 Prix Galien UK...

The Galien Foundation Announces New Prix Galien UK Award Category for "Best Health Equity Innovation"

The Galien Foundation Announces New Prix Galien UK Award Category for "Best Health Equity Innovation"

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced a new Prix Galien UK Award...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.